Coverage Initiated on Immunotherapy Developer with Phase 3 Lead Asset
June 20, 2018 at 04:00 AM EDT
Source: Streetwise Reports 06/20/2018 A B. Riley FBR report provided an overview of this life sciences firm. In a June 6 research note, analyst Madhu Kumar indicated B. Riley FBR initiated coverage on Immunomedics, Inc. [...]
